Publications

• Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
  Lancet Neurol Volume: 23 Page(s): 465 - 476
  05/01/2024 Authors: Espay AJ; Stocchi F; Pahwa R; Albanese A; Ellenbogen A; Ferreira JJ; Giladi N; Gurevich T; Hassin-Baer S; Hernandez-Vara J
• Identification of PSMB5 as a genetic modifier of fragile X-associated tremor/ataxia syndrome.
  Proc Natl Acad Sci U S A Volume: 119 Page(s): e2118124119
  05/31/2022 Authors: Kong HE; Lim J; Linsalata A; Kang Y; Malik I; Allen EG; Cao Y; Shubeck L; Johnston R; Huang Y
• Pseudonystagmus in progressive supranuclear palsy.
  J Neurol Sci Volume: 434 Page(s): 120157
  03/15/2022 Authors: Ticku H; Fotedar N; Juncos J; Factor SA; Shaikh AG
• Exploratory evaluation of baseline cognition as a predictor of perceived benefit in a study of behavioral therapy for urinary incontinence in Parkinson disease.
  Neurourol Urodyn Volume: 41 Page(s): 841 - 846
  03/01/2022 Authors: Chang PL; Goldstein FC; Burgio KL; Juncos JL; McGwin G; Muirhead L; Markland AD; Johnson TM; Vaughan CP
• Secondary Dystonia in a Novel Mitochondriopathy Responsive to Deep Brain Stimulation Therapy.
  Mov Disord Clin Pract Volume: 8 Page(s): 135 - 138
  01/01/2021 Authors: Sharma VD; Buetefisch CM; Kendall FD; Gross RE; DeLong MR; Juncos JL
• Diagnosing functional neurological disorder: seeing the whole picture.
  CNS Spectr Page(s): 1 - 8
  11/09/2020 Authors: Lidstone SC; Nassif W; Juncos J; Factor SA; Lang AE
• Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
  Parkinsonism Relat Disord Volume: 69 Page(s): 34 - 39
  12/01/2019 Authors: Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C
• Hypertension and progressive supranuclear palsy.
  Parkinsonism Relat Disord Volume: 66 Page(s): 166 - 170
  09/01/2019 Authors: Rabadia SV; Litvan I; Juncos J; Bordelon Y; Riley DE; Standaert D; Reich SG; Hall DA; Kluger B; Shprecher D
• Behavioral therapy for urinary symptoms in Parkinson's disease: A randomized clinical trial.
  Neurourol Urodyn Volume: 38 Page(s): 1737 - 1744
  08/01/2019 Authors: Vaughan CP; Burgio KL; Goode PS; Juncos JL; McGwin G; Muirhead L; Markland AD; Johnson TM
• Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.
  Alzheimer Dis Assoc Disord Volume: 33 Page(s): 327 - 330
  01/01/2019 Authors: Ayer AH; Wojta K; Ramos EM; Dokuru D; Chen JA; Karydas AM; Papatriantafyllou JD; Agiomyrgiannakis D; Kamtsadeli V; Tsinia N
• IDENTIFICATION OF VARIOUS ABNORMAL MOVEMENTS BY PROPER NEUROLOGICAL EXAMINATION AND DIFFERENTIAL DIAGNOSIS
  Volume: 57 Page(s): S55 - S55
  10/01/2018 Authors: Juncos J
• Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
  Mov Disord Volume: 33 Page(s): 1272 - 1280
  08/01/2018 Authors: Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE
• Increased odds of bladder and bowel symptoms in early Parkinson's disease.
  Neurourol Urodyn Volume: 37 Page(s): 1344 - 1348
  04/01/2018 Authors: Serra MC; Landry A; Juncos JL; Markland AD; Burgio KL; Goode PS; Johnson TM; Vaughan CP
• Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
  CNS Drugs Volume: 32 Page(s): 387 - 398
  04/01/2018 Authors: Elmer LW; Juncos JL; Singer C; Truong DD; Criswell SR; Parashos S; Felt L; Johnson R; Patni R
• Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
  CNS Drugs Volume: 32 Page(s): 399 - 400
  04/01/2018 Authors: Elmer LW; Juncos JL; Singer C; Truong DD; Criswell SR; Parashos S; Felt L; Johnson R; Patni R
• PELVIC FLOOR MUSCLE EXERCISE-BASED BEHAVIORAL THERAPY IMPROVES URINARY SYMPTOMS IN PARKINSON DISEASE
  Volume: 199 Page(s): E728 - E728
  04/01/2018 Authors: Vaughan C; Burgio K; Goode P; Juncos J; Muirhead L; McGwin G; Johnson T
• Behavioral therapy improves urinary symptoms in Parkinson disease
  Volume: 66 Page(s): S11 - S11
  04/01/2018 Authors: Vaughan CP; Burgio K; Goode P; Juncos J; Muirhead L; McGwin G; Johnson T
• Anti-inflammatory drug use and progressive supranuclear palsy.
  Parkinsonism Relat Disord Volume: 48 Page(s): 89 - 92
  03/01/2018 Authors: Marras C; Cunningham CR; Hou J; Proudfoot J; Standaert DG; Juncos J; Riley D; Reich SG; Hall D; Kluger B
• PELVIC FLOOR MUSCLE EXERCISE-BASED BEHAVIOURAL THERAPY IMPROVES URINARY SYMPTOMS IN PARKINSON DISEASE
  Volume: 66 Page(s): 357 - 357
  02/01/2018 Authors: Vaughan CP; Burgio K; Goode P; Juncos J; Muirhead L; McGwin G; Johnson T
• Fixational eye movements in Tourette syndrome.
  Neurol Sci Volume: 38 Page(s): 1977 - 1984
  11/01/2017 Authors: Shaikh AG; Finkelstein SR; Schuchard R; Ross G; Juncos JL
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE D1 RECEPTOR ANTAGONIST ECOPIPAM FOR CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER
  Volume: 56 Page(s): S241 - S241
  10/01/2017 Authors: Murphy TK; Gilbert D; Budman CL; Black KJ; Jankovic J; Grant J; McCracken JT; Coffman KA; Juncos J; Kurlan R
• Pelvic floor muscle exercise-based behavioral therapy improves urinary symptoms in Parkinson disease
  Volume: 32 Page(s): E18 - E18
  09/01/2017 Authors: Vaughan CP; Burgio KL; Goode PS; Juncos JL; McGwin G; Johnson TM
• Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort.
  J Neurol Sci Volume: 377 Page(s): 137 - 143
  06/15/2017 Authors: Chou KL; Elm JJ; Wielinski CL; Simon DK; Aminoff MJ; Christine CW; Liang GS; Hauser RA; Sudarsky L; Umeh CC
• Understanding falls in progressive supranuclear palsy.
  Parkinsonism Relat Disord Volume: 35 Page(s): 75 - 81
  02/01/2017 Authors: Bluett B; Litvan I; Cheng S; Juncos J; Riley DE; Standaert DG; Reich SG; Hall DA; Kluger B; Shprecher D
• Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slow.
  Mov Disord Clin Pract Volume: 4 Page(s): 671 - 681
  01/01/2017 Authors: Shaikh AG; Factor SA; Juncos J
• Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.
  Mov Disord Volume: 31 Page(s): 644 - 652
  05/01/2016 Authors: Litvan I; Lees PSJ; Cunningham CR; Rai SN; Cambon AC; Standaert DG; Marras C; Juncos J; Riley D; Reich S
• Predictors of Cognitive Decline in FXTAS
  Volume: 86
  04/05/2016 Authors: Lazarus J; Shubeck L; Allen E; Hamilton D; Choi J; Sherman S; Juncos J
• Predictors of Cognitive Decline in FXTAS
  Volume: 86
  04/05/2016 Authors: Lazarus J; Shubeck L; Allen E; Hamilton D; Choi J; Sherman S; Juncos J
• Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
  Nat Commun Volume: 6 Page(s): 7247
  06/16/2015 Authors: Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J
• Tourette syndrome deep brain stimulation: a review and updated recommendations.
  Mov Disord Volume: 30 Page(s): 448 - 471
  04/01/2015 Authors: Schrock LE; Mink JW; Woods DW; Porta M; Servello D; Visser-Vandewalle V; Silburn PA; Foltynie T; Walker HC; Shahed-Jimenez J
• Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases.
  Eur J Hum Genet Volume: 23 Page(s): 292 - 301
  03/01/2015 Authors: Verloes A; Di Donato N; Masliah-Planchon J; Jongmans M; Abdul-Raman OA; Albrecht B; Allanson J; Brunner H; Bertola D; Chassaing N
• Organochlorine chemicals and neurodegeneration among elderly subjects in Costa Rica.
  Environ Res Volume: 134 Page(s): 205 - 209
  10/31/2014 Authors: Steenland K; Mora AM; Barr DB; Juncos J; Roman N; Wesseling C
• Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
  Parkinsonism Relat Disord Volume: 20 Page(s): 644 - 646
  06/01/2014 Authors: Moonen AJH; Wijers A; Leentjens AFG; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R
• A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
  JAMA Neurol Volume: 71 Page(s): 543 - 552
  05/01/2014 Authors: Parkinson Study Group QE3 Investigators; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS
• Parkinson's and Alzheimer's diseases in Costa Rica: a feasibility study toward a national screening program.
  Glob Health Action Volume: 6 Page(s): 23061
  12/27/2013 Authors: Wesseling C; Romn N; Quirs I; Pez L; Garca V; Mora AM; Juncos JL; Steenland KN
• The effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's disease.
  Parkinsonism Relat Disord Volume: 19 Page(s): 955 - 960
  11/01/2013 Authors: Amano S; Nocera JR; Vallabhajosula S; Juncos JL; Gregor RJ; Waddell DE; Wolf SL; Hass CJ
• Nocturia and overnight polysomnography in Parkinson disease.
  Neurourol Urodyn Volume: 32 Page(s): 1080 - 1085
  11/01/2013 Authors: Vaughan CP; Juncos JL; Trotti LM; Johnson TM; Bliwise DL
• Autonomic Dysfunction in the Fragile X Associated Tremor/Ataxia Syndrome
  Volume: 80
  02/12/2013 Authors: Lazarus J; Allen E; Shubeck L; Sherman S; Juncos J
• Occupational pesticide exposure and screening tests for neurodegenerative disease among an elderly population in Costa Rica.
  Environ Res Volume: 120 Page(s): 96 - 101
  01/01/2013 Authors: Steenland K; Wesseling C; Romn N; Quirs I; Juncos JL
• Parkinson's and Alzheimer's diseases in Costa Rica: a feasibility study toward a national screening program.
  Glob Health Action Volume: 6 Page(s): 23061
  01/01/2013 Authors: Wesseling C; Romn N; Quirs I; Pez L; Garca V; Mara Mora A; Juncos JL; Steenland KN
• Daytime REM sleep in Parkinson's disease.
  Parkinsonism Relat Disord Volume: 19 Page(s): 101 - 103
  01/01/2013 Authors: Bliwise DL; Trotti LM; Juncos JJ; Factor SA; Freeman A; Rye DB
• Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.
  Mov Disord Volume: 27 Page(s): 1513 - 1521
  10/01/2012 Authors: Elm JJ; NINDS NET-PD Investigators
• Reliability of a new scale for essential tremor.
  Mov Disord Volume: 27 Page(s): 1567 - 1569
  10/01/2012 Authors: Elble R; Comella C; Fahn S; Hallett M; Jankovic J; Juncos JL; Lewitt P; Lyons K; Ondo W; Pahwa R
• Olfactory dysfunction in fragile X tremor ataxia syndrome.
  Mov Disord Volume: 27 Page(s): 1556 - 1559
  10/01/2012 Authors: Juncos JL; Lazarus JT; Rohr J; Allen EG; Shubeck L; Hamilton D; Novak G; Sherman SL
• Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
  Hum Mol Genet Volume: 21 Page(s): 3500 - 3512
  08/01/2012 Authors: Coppola G; Chinnathambi S; Lee JJ; Dombroski BA; Baker MC; Soto-Ortolaza AI; Lee SE; Klein E; Huang AY; Sears R
• Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.
  Mov Disord Volume: 27 Page(s): 1118 - 1124
  08/01/2012 Authors: Bliwise DL; Trotti LM; Wilson AG; Greer SA; Wood-Siverio C; Juncos JJ; Factor SA; Freeman A; Rye DB
• A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
  Neurology Volume: 78 Page(s): 1229 - 1236
  04/17/2012 Authors: Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M
• Nocturia and overnight polysomnography outcomes among adults with Parkinson disease.
  Volume: 60 Page(s): S99 - S99
  04/01/2012 Authors: Vaughan CP; Juncos JL; Trotti LM; Johnson TM; Bliwise DL
• Nocturia and Overnight Polysomnography Outcomes among Adults with Parkinson Disease.
  Volume: 27 Page(s): E7 - E7
  04/01/2012 Authors: Vaughan C; Juncos J; Trotti L; Johnson T; Bliwise D
• Behavioral Therapy without EMG-Biofeedback Training is Feasible to Treat Urinary Incontinence in Parkinson Disease.
  Volume: 27 Page(s): E7 - E7
  04/01/2012 Authors: Vaughan C; Juncos J; Burgio K; Goode P; Johnson T
• Autonomic dysfunction in FMR1 premutation carriers as measured by the SCOPA-AU
  Volume: 27 Page(s): E9 - E10
  04/01/2012 Authors: Lazarus JT; Graves-Allen E; Shubeck L; Sherman SL; Juncos JL
• FURTHER EVIDENCE OF A NARCOLEPTIC PHENOTYPE IN PARKINSON'S DISEASE (PD)
  Volume: 35 Page(s): A280 - A280
  01/01/2012 Authors: Bliwise DL; Trotti L; Juncos J; Factor SA; Wilson A; Greer S; Rye DB
• BEDPARTNER REPORTED DREAM ENACTMENT BEHAVIOR MEASURED WITH THE UNIVERSITY OF MICHIGAN RBD QUESTIONNAIRE (UMRBDQ) CORRELATES WITH DAYTIME ALERTNESS INDEPENDENTLY FROM MOTOR DISABILITY IN PARKINSON'S DISEASE (PD)
  Volume: 35 Page(s): A438 - A438
  01/01/2012 Authors: Bliwise DL; Trotti L; Juncos J; Factor SA; Wilson A; Greer S; Rye DB
• Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
  Nat Genet Volume: 43 Page(s): 699 - 705
  06/19/2011 Authors: Hglinger GU; Melhem NM; Dickson DW; Sleiman PMA; Wang L-S; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE
• Behavioral therapy to treat urinary incontinence in Parkinson disease.
  Neurology Volume: 76 Page(s): 1631 - 1634
  05/10/2011 Authors: Vaughan CP; Juncos JL; Burgio KL; Goode PS; Wolf RA; Johnson TM
• New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS).
  Neurogenetics Volume: 12 Page(s): 123 - 135
  05/01/2011 Authors: Juncos JL; Lazarus JT; Graves-Allen E; Shubeck L; Rusin M; Novak G; Hamilton D; Rohr J; Sherman SL
• Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.
  Neuropsychology Volume: 25 Page(s): 404 - 411
  05/01/2011 Authors: Allen EG; Hunter JE; Rusin M; Juncos J; Novak G; Hamilton D; Shubeck L; Charen K; Sherman SL
• Change in urgency urinary incontinence among participants in the BETTUR PD pilot study.
  Volume: 59 Page(s): S142 - S143
  04/01/2011 Authors: Vaughan CP; McGwin G; Juncos JL; Burgio KL; Goode PS; Johnson TM
• LEVO-DOPA (L-DOPA) AND DOPAMINE AGONIST (DA)-NAIVE IDIOPATHIC PARKINSON'S DISEASE (PD) PATIENTS DEMONSTRATE MAINTENANCE OF WAKEFULNESS TEST (MWT)-DEFINED ALERTNESS
  Volume: 34 Page(s): A220 - A221
  01/01/2011 Authors: Bliwise DL; Trotti L; Wilson A; Greer S; Juncos J; Rye DB; Factor SA; Freeman A; Hollars S; Wood-Siverio C
• DIFFERENTIAL ASSOCIATIONS BETWEEN LEVO-DOPA (L-DOPA) VS DOPAMINE AGONIST (DA) DOSE AND MAINTENANCE OF WAKEFULNESS TEST (MWT) MEASURES OF ALERTNESS IN IDIOPATHIC PARKINSON'S DISEASE (PD)
  Volume: 34 Page(s): A221 - A221
  01/01/2011 Authors: Bliwise DL; Trotti L; Wilson A; Greer S; Juncos J; Rye DB; Factor SA; Freeman A; Hollars S; Wood-Siverio C
• Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease.
  Parkinsonism Relat Disord Volume: 16 Page(s): 535 - 539
  09/01/2010 Authors: Bickel S; Alvarez L; Macias R; Pavon N; Leon M; Fernandez C; Houghton DJ; Salazar S; Rodrguez-Oroz MC; Juncos J
• Phasic muscle activity in sleep and clinical features of Parkinson disease.
  Ann Neurol Volume: 68 Page(s): 353 - 359
  09/01/2010 Authors: Bliwise DL; Trotti LM; Greer SA; Juncos JJ; Rye DB
• Behavioral therapy to treat urinary incontinence in Parkinson's disease (BETTUR PD).
  Volume: 58 Page(s): 98 - 98
  04/01/2010 Authors: Vaughan C; Juncos JL; Burgio KL; Goode PS; Johnson TM
• HOUR-TO-HOUR FLUCTUATIONS IN DIGIT SPAN (DS) PERFORMANCE IN PARKINSON'S DISEASE (PD): RELATION TO MWT-DEFINED ALERTNESS
  SLEEP Volume: 33 Page(s): A282 - A282
  01/01/2010 Authors: Wilson A; Hollars S; Greer S; Trotti L; Juncos J; Factor SA; Freeman A; Wood-Siverio C; Rye DB; Bliwise DL
• ORTHOSTASIS ACROSS PARKINSONIAN SYNDROMES ASSOCIATED WITH LOWER MWT-DEFINED ALERTNESS
  SLEEP Volume: 33 Page(s): A281 - A282
  01/01/2010 Authors: Bliwise DL; Wilson A; Hollars S; Greer S; Trotti L; Juncos J; Factor SA; Freeman A; Wood-Siverio C; Rye DB
• MWT, BUT NOT IMPAIRED OLFACTION, DIFFERENTIATES PARKINSON'S DISEASE (PD) FROM IDIOPATHIC REM BEHAVIOR DISORDER (RBD)
  SLEEP Volume: 33 Page(s): A274 - A274
  01/01/2010 Authors: Trotti L; Juncos J; Factor SA; Freeman A; Wilson A; Hollars S; Greer S; Wood-Siverio C; Rye DB; Bliwise DL
• Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
  Lancet Neurol Volume: 8 Page(s): 1140 - 1149
  12/01/2009 Authors: Voon V; Fernagut P-O; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
• Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months.
  J Neurol Neurosurg Psychiatry Volume: 80 Page(s): 979 - 985
  09/01/2009 Authors: Alvarez L; Macias R; Pavn N; Lpez G; Rodrguez-Oroz MC; Rodrguez R; Alvarez M; Pedroso I; Teijeiro J; Fernndez R
• Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/ataxia syndrome.
  Acta Neurol Scand Volume: 119 Page(s): 135 - 138
  02/01/2009 Authors: Zesiewicz TA; Sullivan KL; Freeman A; Juncos JL
• TIME UNDERESTIMATION IN A BEDSIDE EXAMINATION IS RELATED TO MWT-DEFINED ALERTNESS IN PARKINSONIAN PATIENTS
  Volume: 32 Page(s): A246 - A246
  01/01/2009 Authors: Wilson AG; Greer SA; Juncos JJ; Trotti L; Rye DB; Bliwise DL
• Gait initiation in older adults with postural instability.
  Clin Biomech (Bristol) Volume: 23 Page(s): 743 - 753
  07/01/2008 Authors: Hass CJ; Waddell DE; Wolf SL; Juncos JL; Gregor RJ
• Detection of early FXTAS motor symptoms using the CATSYS computerised neuromotor test battery.
  J Med Genet Volume: 45 Page(s): 290 - 297
  05/01/2008 Authors: Allen EG; Juncos J; Letz R; Rusin M; Hamilton D; Novak G; Shubeck L; Tinker SW; Sherman SL
• Subjective versus Objective Measures of Gait Function: Accuracy in Parkinson Disease
  MEDICINE AND SCIENCE IN SPORTS AND EXERCISE Volume: 40 Page(s): S19 - S19
  05/01/2008 Authors: Hass CJ; Buckley T; Juncos JL
• Phenotypic variability and symptom time course in the FX tremor ataxia syndrome
  Volume: 70 Page(s): A320 - A320
  03/11/2008 Authors: Juncos JL; Allen EG; Shubeck L; Novak G; Hamilton DR; Sherman SR
• Progressive supranuclear palsy: a current review.
  Neurologist Volume: 14 Page(s): 79 - 88
  03/01/2008 Authors: Lubarsky M; Juncos JL
• DBS in Tourette syndrome (TS): A two-year open label experience in two patients
  Volume: 23 Page(s): S112 - S112
  01/01/2008 Authors: Juncos JL; Gross R; Delong MR
• Aripiprazole associated movement disorders
  Volume: 23 Page(s): S239 - S239
  01/01/2008 Authors: Aia PG; Esper CD; Juncos JL; Factor SA
• A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.
  Schizophr Res Volume: 93 Page(s): 42 - 50
  07/01/2007 Authors: George MS; Molnar CE; Grenesko EL; Anderson B; Mu Q; Johnson K; Nahas Z; Knable M; Fernandes P; Juncos J
• A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease.
  Neurology Volume: 68 Page(s): 20 - 28
  01/02/2007 Authors: NINDS NET-PD Investigators
• Resistance training with creatine monohydrate improves upper-body strength in patients with Parkinson disease: a randomized trial.
  Neurorehabil Neural Repair Volume: 21 Page(s): 107 - 115
  01/01/2007 Authors: Hass CJ; Collins MA; Juncos JL
• Report from a U.S. conference on essential tremor.
  Mov Disord Volume: 21 Page(s): 2052 - 2061
  12/01/2006 Authors: Elble RJ; Tremor Research Group
• Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease.
  Mov Disord Volume: 21 Page(s): 2127 - 2133
  12/01/2006 Authors: Craig LH; Svircev A; Haber M; Juncos JL
• Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome.
  Mov Disord Volume: 21 Page(s): 1831 - 1838
  11/01/2006 Authors: Mink JW; Walkup J; Frey KA; Como P; Cath D; Delong MR; Erenberg G; Jankovic J; Juncos J; Leckman JF
• A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia.
  Am J Hum Genet Volume: 78 Page(s): 947 - 960
  06/01/2006 Authors: Procaccio V; Salazar G; Ono S; Styers ML; Gearing M; Davila A; Jimenez R; Juncos J; Gutekunst C-A; Meroni G
• A controlled study of aerobic exercise and Chinese exercise modalities in Parkinson disease
  Volume: 66 Page(s): 314 - 314
  03/14/2006 Authors: Juncos JL; Haber M; Hass CS; Waddell D; Gregor R; Wolf SL
• Resistance training and creatine supplementation in Parkinson's disease
  Volume: 21 Page(s): S130 - S130
  01/01/2006 Authors: Hass CJ; Collins MA; Juncos JL
• Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders".
  Biol Psychiatry Volume: 58 Page(s): 916
  12/01/2005 Authors: Gilbert D; Gerber MA
• Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders".
  Biol Psychiatry Volume: 58 Page(s): 917
  12/01/2005 Authors: Budman C; Coffey B; Dure L; Gilbert D; Juncos J; Kaplan E; King R; Kurlan R; Lowe T; Mack K
• Gait initiation and dynamic balance control in Parkinson's disease.
  Arch Phys Med Rehabil Volume: 86 Page(s): 2172 - 2176
  11/01/2005 Authors: Hass CJ; Waddell DE; Fleming RP; Juncos JL; Gregor RJ
• A controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease
  Volume: 20 Page(s): 1242 - 1242
  09/01/2005 Authors: Craig LH; Svircev A; Haber M; Juncos JL
• The Effects Of Acute Creatine Supplementation On Muscle Strength In Patients With Parkinson's Disease
  MEDICINE AND SCIENCE IN SPORTS AND EXERCISE Volume: 37 Page(s): S363 - S363
  05/01/2005 Authors: Collins MA; Hass CJ; Morris D; Juncos JL
• Resistance Training Combined With Creatine Supplementation In Patients With Parkinson's Disease
  MEDICINE AND SCIENCE IN SPORTS AND EXERCISE Volume: 37 Page(s): S337 - S337
  05/01/2005 Authors: Hass CJ; Collins MA; Morris D; Juncos JL
• Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
  Brain Volume: 128 Page(s): 570 - 583
  03/01/2005 Authors: Alvarez L; Macias R; Lopez G; Alvarez E; Pavon N; Rodriguez-Oroz MC; Juncos JL; Maragoto C; Guridi J; Litvan I
• A pilot study examining the effects of neuromuscular therapy on patients with Parkinson's disease.
  J Am Osteopath Assoc Volume: 105 Page(s): 26
  01/01/2005 Authors: Svircev A; Craig LH; Juncos JL
• Levodopa and the progression of Parkinson's disease.
  N Engl J Med Volume: 351 Page(s): 2498 - 2508
  12/09/2004 Authors: Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; Parkinson Study Group
• Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.
  Neurology Volume: 63 Page(s): 1376 - 1384
  10/26/2004 Authors: Cairns NJ; Grossman M; Arnold SE; Burn DJ; Jaros E; Perry RH; Duyckaerts C; Stankoff B; Pillon B; Skullerud K
• Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus.
  J Neurol Neurosurg Psychiatry Volume: 75 Page(s): 921 - 923
  06/01/2004 Authors: Okun MS; Raju DV; Walter BL; Juncos JL; DeLong MR; Heilman K; McDonald WM; Vitek JL
• Measuring the effects of therapy in Parkinson disease.
  JAMA Volume: 291 Page(s): 2430 - 2431
  05/26/2004 Authors: Shults CW; Haas R; Oakes D; Kieburtz K; Plumb S; Shoulson I; Beal MF; Juncos J; Nutt J
• Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
  Mov Disord Volume: 19 Page(s): 29 - 35
  01/01/2004 Authors: Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou H-C; Yeung PP
• The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.
  Arch Neurol Volume: 60 Page(s): 1170 - 1172
  08/01/2003 Authors: Horstink MWIM; van Engelen BG
• A pilot study examining the effects of neuromuscular massage therapy (NMT) on reported sleep in Parkinson's disease (PD)
  Volume: 26 Page(s): A346 - A346
  05/15/2003 Authors: Svircev A; Craig L; Ansari FP; Juncos JL; Bliwise DL
• Unusual neuropathologic findings in a case of primary lateral sclerosis.
  Volume: 62 Page(s): 555 - 555
  05/01/2003 Authors: Gearing M; Castellano AA; Hunter SB; Brat DJ; Glass JD; Santoianni R; Juncos JL
• Benefits and risks of pharmacological treatments for essential tremor.
  Drug Saf Volume: 26 Page(s): 461 - 481
  01/01/2003 Authors: Lyons KE; Pahwa R; Comella CL; Eisa MS; Elble RJ; Fahn S; Jankovic J; Juncos JL; Koller WC; Ondo WG
• Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease.
  Arch Neurol Volume: 59 Page(s): 1750 - 1753
  11/01/2002 Authors: Okun MS; Walter BL; McDonald WM; Tenover JL; Green J; Juncos JL; DeLong MR
• Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
  Arch Neurol Volume: 59 Page(s): 1541 - 1550
  10/01/2002 Authors: Shults CW; Oakes D; Kieburtz K; Beal MF; Haas R; Plumb S; Juncos JL; Nutt J; Shoulson I; Carter J
• Aggregation of actin and cofilin in identical twins with juvenile-onset dystonia.
  Ann Neurol Volume: 52 Page(s): 465 - 476
  10/01/2002 Authors: Gearing M; Juncos JL; Procaccio V; Gutekunst C-A; Marino-Rodriguez EM; Gyure KA; Ono S; Santoianni R; Krawiecki NS; Wallace DC
• Broad peak motor unit synchrony in Parkinson's disease is not explained solely by tremor
  Volume: 52 Page(s): S48 - S48
  09/01/2002 Authors: Waddell DE; Wolf SL; Gregor RJ; Juncos JL
• Bilateral dorsal subthalamotomy in Parkinson's disease: 2-year follow-up
  Volume: 52 Page(s): S35 - S35
  09/01/2002 Authors: Lazaro AM; Alvarez L; Macias R; Lopez G; Alvarez E; Perez S; Maragoto C; Leon M; Palmero K; Pavon N
• Actin aggregation in identical twins with dystonia: Consequence of a defect in bioenergetics.
  JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 61 Page(s): 460 - 460
  05/01/2002 Authors: Gearing M; Procaccio V; Ono S; Juncos JL; Wainer BH
• Long-term prognosis of hallucinating Parkinson's disease patients treated with quetiapine or clozapine
  Volume: 58 Page(s): A435 - A435
  04/09/2002 Authors: Juncos JL; Jewart RD; Neparizde N; Hanfelt J
• Treatment of ADHD in children with tics: a randomized controlled trial.
  Neurology Volume: 58 Page(s): 527 - 536
  02/26/2002 Authors: Tourette's Syndrome Study Group
• Bilateral dorsal subthalamotomy in Parkinson's disease (PD): Initial response and evolution after 2 years
  Volume: 17 Page(s): S95 - S95
  01/01/2002 Authors: Alvarez L; Macias R; Lopez G; Alvarez E; Maragoto C; Obeso JA; Pavon N; Rodriguez-Oroz MC; Juncos J; Guridi J
• Complications of gamma knife surgery for Parkinson disease.
  Arch Neurol Volume: 58 Page(s): 1995 - 2002
  12/01/2001 Authors: Okun MS; Stover NP; Subramanian T; Gearing M; Wainer BH; Holder CA; Watts RL; Juncos JL; Freeman A; Evatt ML
• Lesion of the basal ganglia and surgery for Parkinson disease.
  Arch Neurol Volume: 58 Page(s): 1165 - 1166
  07/01/2001 Authors: Obeso JA; Rodriguez MC; Guridi J; Alvarez L; Alvarez E; Macias R; Juncos JL; DeLong M
• Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.
  Mov Disord Volume: 16 Page(s): 459 - 463
  05/01/2001 Authors: Hutton JT; Metman LV; Chase TN; Juncos JL; Koller WC; Pahwa R; LeWitt PA; Samii A; Tsui JK; Calne DB
• Dorsal subthalamotomy for Parkinson's disease (vol 16, pg 72, 2001)
  MOVEMENT DISORDERS Volume: 16 Page(s): 584 - 584
  05/01/2001 Authors: Alvarez L; Macias R; Guridi J; Lopez G; Alvarez E; Maragoto C; Teijeiro J; Torres A; Pavon N; Rodriguez-Oroz MC
• Multiple system atrophy (MSA) and Parkinson's disease (PD) pathology with diffuse cortical Lewy bodies in a patient evidencing multiple clinical phenotypes.
  JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 60 Page(s): 548 - 548
  05/01/2001 Authors: Gearing M; Juncos JL; Farrer M; Lincoln S; Wainer BH
• Bilateral subthalamotomy in Parkinson's disease
  Volume: 56 Page(s): A273 - A273
  04/24/2001 Authors: Alvarez L; Macias R; Rodriguez-Oroz MC; Lopez G; Alvarez E; Guridi J; Juncos JL; Tolosa ES; Koller WC; Litvan L
• Complications of Gamma Knife surgery for Parkinson's Disease
  Volume: 56 Page(s): A279 - A280
  04/24/2001 Authors: Okun MS; Holder C; Bruce W; Stover NP; Watts RL; Juncos JL; Freeman A; Evatt M; Vitek JL; DeLong MR
• Dorsal subthalamotomy for Parkinson's disease.
  Mov Disord Volume: 16 Page(s): 72 - 78
  01/01/2001 Authors: Alvarez L; Macias R; Guridi J; Lopez G; Alvarez E; Maragoto C; Teijeiro J; Torres A; Pavon N; Rodriguez-Oroz MC
• Quetiapine treatment of psychotic symptoms in lewy body dementia: Long-term experience in 10 patients with three pathologically confirmed cases
  ANNALS OF NEUROLOGY Volume: 48 Page(s): 418 - 418
  09/01/2000 Authors: Juncos JL; Jewart DR; Gearing M; Wainer B
• Unusual neuropathology in an identical twin with juvenile-onset dystonia negative for the DYT1 GAG deletion.
  Volume: 59 Page(s): 465 - 465
  05/01/2000 Authors: Gearing M; Juncos JL; Gutekunst CA; Marino E; Wainer BH
• Long-term quetiapine for psychosis in Parkinson's Disease in place of other antipsychotics
  BIOLOGICAL PSYCHIATRY Volume: 47 Page(s): 42S - 43S
  04/15/2000 Authors: Juncos JL; Evatt ML; Jewart RD; Roberts VJ; Wood CD; Potter LS; Jou HC; Yeung PP
• Long term quetiapine treatment for psychosis in patients with Parkinsonism who failed treatment with other atypical antipsychotics
  Volume: 54 Page(s): A374 - A374
  04/11/2000 Authors: Juncos JL; Evatt ML; Jewart RD; Roberts VJ; Potter LS; Jou HC; Yeung PP
• Quetiapine improves psychotic symptoms associated with Parkinson's disease
  SCHIZOPHRENIA RESEARCH Volume: 36 Page(s): 283 - 283
  04/01/1999 Authors: Juncos J; Yeung P; Sweitzer D; Arvanitis L; Nemeroff C
• Management of psychotic aspects of Parkinson's disease.
  J Clin Psychiatry Volume: 60 Suppl 8 Page(s): 42 - 53
  01/01/1999 Authors: Juncos JL
• Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.
  Neurology Volume: 48 Page(s): 1070 - 1077
  04/01/1997 Authors: Richard IH; Kurlan R; Tanner C; Factor S; Hubble J; Suchowersky O; Waters C
• Lesion of the subthalamic nucleus (STN) in Parkinson's disease (PD)
  Volume: 48 Page(s): 12003 - 12003
  03/01/1997 Authors: Obeso JA; Alvarez LM; Macias RJ; Guridi J; Teijeiro J; Juncos JL; Rodriguez MC; Ramos E; Linazasoro GJ; Gorospe A
• Depression and disability in Parkinson's disease.
  J Neuropsychiatry Clin Neurosci Volume: 8 Page(s): 20 - 25
  01/01/1996 Authors: Cole SA; Woodard JL; Juncos JL; Kogos JL; Youngstrom EA; Watts RL
• Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.
  J Neurosci Volume: 14 Page(s): 6144 - 6152
  10/01/1994 Authors: Hooks MS; Juncos JL; Justice JB; Meiergerd SM; Povlock SL; Schenk JO; Kalivas PW
• Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
  Psychopharmacology (Berl) Volume: 116 Page(s): 217 - 225
  10/01/1994 Authors: Hooks MS; Jones DN; Holtzman SG; Juncos JL; Kalivas PW; Justice JB
• Effects of cocaine microinjections into the nucleus accumbens and medial prefrontal cortex on schedule-induced behaviour: comparison with systemic cocaine administration.
  Psychopharmacology (Berl) Volume: 115 Page(s): 375 - 382
  07/01/1994 Authors: Jones GH; Hooks MS; Juncos JL; Justice JB
• Individual differences in schedule-induced and conditioned behaviors.
  Behav Brain Res Volume: 60 Page(s): 199 - 209
  02/28/1994 Authors: Hooks MS; Jones GH; Juncos JL; Neill DB; Justice JB
• Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.
  Genomics Volume: 17 Page(s): 171 - 184
  07/01/1993 Authors: Shoffner JM; Brown MD; Torroni A; Lott MT; Cabell MF; Mirra SS; Beal MF; Yang CC; Gearing M; Salvo R
• THE EFFECT OF CARDIOVASCULAR TRAINING ON FITNESS AND MOTOR FUNCTION IN PARKINSONS-DISEASE (PD)
  Volume: 43 Page(s): A285 - A285
  04/01/1993 Authors: JUNCOS JL; MILLARD TL; CATLIN PA
• SCID-DIAGNOSED DSM-III-R ANXIETY DISORDERS IN PRIMARY DYSTONIA
  BIOLOGICAL PSYCHIATRY Volume: 33 Page(s): A151 - A151
  03/15/1993 Authors: LAUTERBACH EC; PRICE ST; FREEMAN A; SPEARS TE; JUNCOS JL; WATTS RL
• DIS-DIAGNOSED DSM-III ANXIETY DISORDERS IN PRIMARY DYSTONIA
  BIOLOGICAL PSYCHIATRY Volume: 33 Page(s): A149 - A149
  03/15/1993 Authors: LAUTERBACH EC; PRICE ST; FREEMAN A; SPEARS TE; JUNCOS JL; WATTS RL
• DIS-DIAGNOSED DSM-III COMPULSIVE DISORDERS IN PRIMARY DYSTONIA
  BIOLOGICAL PSYCHIATRY Volume: 33 Page(s): A149 - A149
  03/15/1993 Authors: LAUTERBACH EC; PRICE ST; FREEMAN A; SPEARS TE; JUNCOS JL; WATTS RL
• SCID-DIAGNOSED DSM-III-R COMPULSIVE DISORDERS IN PRIMARY DYSTONIA
  BIOLOGICAL PSYCHIATRY Volume: 33 Page(s): A151 - A151
  03/15/1993 Authors: LAUTERBACH EC; PRICE ST; FREEMAN A; SPEARS TE; JUNCOS JL; WATTS RL
• Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis.
  Brain Res Volume: 587 Page(s): 306 - 312
  08/07/1992 Authors: Hooks MS; Colvin AC; Juncos JL; Justice JB
• Mitochondrial oxidative phosphorylation defects in Parkinson's disease.
  Ann Neurol Volume: 32 Page(s): 113 - 114
  07/01/1992 Authors: Wallace DC; Shoffner JM; Watts RL; Juncos JL; Torroni A
• Levodopa: pharmacology, pharmacokinetics, and pharmacodynamics.
  Neurol Clin Volume: 10 Page(s): 487 - 509
  05/01/1992 Authors: Juncos JL
• Clozapine is beneficial for psychosis in Parkinson's disease.
  Neurology Volume: 41 Page(s): 1699 - 1700
  10/01/1991 Authors: Kahn N; Freeman A; Juncos JL; Manning D; Watts RL
• Mitochondrial oxidative phosphorylation defects in Parkinson's disease.
  Ann Neurol Volume: 30 Page(s): 332 - 339
  09/01/1991 Authors: Shoffner JM; Watts RL; Juncos JL; Torroni A; Wallace DC
• Electrophysiologic analysis of early Parkinson's disease.
  Geriatrics Volume: 46 Suppl 1 Page(s): 31 - 36
  08/01/1991 Authors: Watts RL; Mandir AS; Ahn KJ; Juncos JL; Zakers GO; Freeman A
• Electrophysiologic analysis of early Parkinson's disease.
  Neurology Volume: 41 Page(s): 44 - 48
  05/01/1991 Authors: Watts RL; Mandir AS; Ahn KJ; Juncos JL; Zakers GO; Freeman A
• ELECTROPHYSIOLOGIC ANALYSIS OF EARLY PARKINSONS-DISEASE
  Volume: 41 Page(s): 44 - 49
  05/01/1991 Authors: WATTS RL; MANDIR AS; AHN KJ; JUNCOS JL; ZAKERS GO; FREEMAN A
• Mesencephalic cholinergic nuclei in progressive supranuclear palsy.
  Neurology Volume: 41 Page(s): 25 - 30
  01/01/1991 Authors: Juncos JL; Hirsch EC; Malessa S; Duyckaerts C; Hersh LB; Agid Y
• Selective deficits in cognition and memory in high-functioning parkinsonian patients.
  J Neurol Neurosurg Psychiatry Volume: 53 Page(s): 603 - 606
  07/01/1990 Authors: Mohr E; Juncos J; Cox C; Litvan I; Fedio P; Chase TN
• Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status.
  J Neurol Neurosurg Psychiatry Volume: 53 Page(s): 279 - 283
  04/01/1990 Authors: Pullman SL; Watts RL; Juncos JL; Sanes JN
• Anxiety disorders in patients with Parkinson's disease.
  Am J Psychiatry Volume: 147 Page(s): 217 - 220
  02/01/1990 Authors: Stein MB; Heuser IJ; Juncos JL; Uhde TW
• Motor response complications with chronic levodopa therapy.
  Adv Neurol Volume: 53 Page(s): 377 - 381
  01/01/1990 Authors: Chase TN; Fabbrini G; Juncos JL; Mouradian MM
• Rationale for continuous dopaminomimetic therapy of Parkinson's disease.
  Volume: 39 Page(s): 7 - 10
  11/01/1989 Authors: Chase TN; Baronti F; Fabbrini G; Heuser IJ; Juncos JL; Mouradian MM
• Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists.
  Eur J Pharmacol Volume: 168 Page(s): 291 - 298
  09/22/1989 Authors: Engber TM; Susel Z; Juncos JL; Chase TN
• Pathogenesis of dyskinesias in Parkinson's disease.
  Ann Neurol Volume: 25 Page(s): 523 - 526
  05/01/1989 Authors: Mouradian MM; Heuser IJ; Baronti F; Fabbrini G; Juncos JL; Chase TN
• Continuous and intermittent levodopa differentially affect basal ganglia function.
  Ann Neurol Volume: 25 Page(s): 473 - 478
  05/01/1989 Authors: Juncos JL; Engber TM; Raisman R; Susel Z; Thibaut F; Ploska A; Agid Y; Chase TN
• Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.
  Neurology Volume: 38 Page(s): 249 - 254
  02/01/1988 Authors: Pullman SL; Watts RL; Juncos JL; Chase TN; Sanes JN
• Pathogenetic studies of motor fluctuations in Parkinson's disease.
  J Neural Transm Suppl Volume: 27 Page(s): 3 - 10
  01/01/1988 Authors: Chase TN; Mouradian MM; Fabbrini G; Juncos JL
• Motor response complications in advanced Parkinson's disease.
  Funct Neurol Volume: 3 Page(s): 429 - 436
  01/01/1988 Authors: Chase TN; Juncos JL; Fabbrini G; Mouradian MM
• Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
  Ann Neurol Volume: 22 Page(s): 475 - 479
  10/01/1987 Authors: Mouradian MM; Juncos JL; Fabbrini G; Chase TN
• Dietary influences on the antiparkinsonian response to levodopa.
  Arch Neurol Volume: 44 Page(s): 1003 - 1005
  10/01/1987 Authors: Juncos JL; Fabbrini G; Mouradian MM; Serrati C; Chase TN
• Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations.
  Arch Neurol Volume: 44 Page(s): 1010 - 1012
  10/01/1987 Authors: Juncos JL; Fabbrini G; Mouradian MM; Chase TN
• Levodopa methyl ester treatment of Parkinson's disease.
  Neurology Volume: 37 Page(s): 1242 - 1245
  07/01/1987 Authors: Juncos JL; Mouradian MM; Fabbrini G; Serrati C; Chase TN
• 3-O-methyldopa and motor fluctuations in Parkinson's disease.
  Neurology Volume: 37 Page(s): 856 - 859
  05/01/1987 Authors: Fabbrini G; Juncos JL; Mouradian MM; Serrati C; Chase TN
• Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease.
  Ann Neurol Volume: 21 Page(s): 370 - 376
  04/01/1987 Authors: Fabbrini G; Juncos J; Mouradian MM; Serrati C; Chase TN
• Idiopathic cranial polyneuropathy. A fifteen-year experience.
  Brain Volume: 110 ( Pt 1) Page(s): 197 - 211
  02/01/1987 Authors: Juncos JL; Beal MF
• Controlled release levodopa treatment of motor fluctuations in Parkinson's disease.
  J Neurol Neurosurg Psychiatry Volume: 50 Page(s): 194 - 198
  02/01/1987 Authors: Juncos JL; Fabbrini G; Mouradian MM; Serrati C; Kask AM; Chase TN
• Fluctuation in response to chronic levodopa therapy: pathogenetic and therapeutic considerations.
  Adv Neurol Volume: 45 Page(s): 477 - 480
  01/01/1987 Authors: Chase TN; Juncos J; Serrati C; Fabbrini G; Bruno G
• Huntington's disease: effect of cysteamine, a somatostatin-depleting agent.
  Neurology Volume: 36 Page(s): 1099 - 1102
  08/01/1986 Authors: Shults C; Steardo L; Barone P; Mohr E; Juncos J; Serrati C; Fedio P; Tamminga CA; Chase TN
• Fluctuating levodopa concentrations and Parkinson's disease.
  Lancet Volume: 2 Page(s): 440
  08/24/1985 Authors: Juncos J; Serrati C; Fabbrini G; Chase TN
• Cholecystokinin-mediated synaptic function and the treatment of neuropsychiatric disease.
  Ann N Y Acad Sci Volume: 448 Page(s): 553 - 561
  01/01/1985 Authors: Chase TN; Barone P; Bruno G; Cohen SL; Juncos J; Knight M; Ruggeri S; Steardo L; Tamminga CA